MemantineVarious toxicities following off-label use: 8 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1867卷 / 1期

关键词：

D O I：

10.1007/s40278-021-00306-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：246 / 246

相关论文

共 50 条

[1] MemantineVarious toxicities following an off label use: 4 case reports
[J]. Reactions Weekly, 2022, 1914 (1) : 282 - 282
[2] TemsirolimusVarious toxicities following off-label use: 8 case reports
[J]. Reactions Weekly, 2021, 1869 (1) : 328 - 328
[3] RituximabVarious toxicities following off-label use: 8 case reports
[J]. Reactions Weekly, 2017, 1669 (1) : 234 - 234
[4] Infliximab/tocilizumabVarious toxicities following off-label use: 8 case reports
[J]. Reactions Weekly, 2023, 1948 (1) : 240 - 240
[5] EltrombopagVarious toxicities and off-label use: 8 case reports
[J]. Reactions Weekly, 2023, 1959 (1) : 265 - 265
[6] Irinotecan/pazopanib/vincristineVarious toxicities following off-label use: 8 case reports
[J]. Reactions Weekly, 2021, 1857 (1) : 184 - 184
[7] ImatinibVarious toxicities following off-label use: 5 case reports
[J]. Reactions Weekly, 2021, 1876 (1) : 164 - 164
[8] RituximabVarious toxicities following an off-label use: 3 case reports
[J]. Reactions Weekly, 2018, 1683 (1) : 600 - 600
[9] DasatinibVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2021, 1881 (1) : 92 - 92
[10] PazopanibVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2023, 1939 (1) : 375 - 375

← 1 2 3 4 5 →